Phio Pharmaceuticals PHIO Balance Sheet (2011-2026)

NASDAQ PHIO
$1.21 +0.06 (+5.22%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Mar2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter)
1.10M1.18M1.14M0.31M0.23M
Assets
Current Assets
Cash & Equivalents (Quarter)
26.53M24.06M20.46M18.02M14.48M11.78M9.04M11.31M8.41M8.49M6.47M4.70M5.39M5.38M13.28M10.78M10.71M21.03M17.03M13.00M
Receivables - Other (Quarter)
Prepaid Assets (Quarter)
0.87M0.62M1.16M1.62M0.84M0.61M0.32M0.68M0.87M0.83M0.37M0.59M0.47M0.35M0.16M0.52M0.79M0.45M0.37M1.30M
Current Assets (Quarter)
27.45M24.73M21.67M19.69M15.38M12.45M9.40M12.04M9.33M9.32M6.85M5.29M5.86M5.74M13.44M11.29M11.49M21.48M17.40M14.30M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.15M0.13M0.21M0.21M0.20M0.18M0.17M0.16M0.14M0.01M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M
Long-Term Investments (Quarter)
Long-Term Deferred Tax (Quarter)
10.15M2.56M0.35M
Other Non-Current Assets (Quarter)
0.05M0.05M0.05M0.05M0.05M0.05M0.01M0.05M0.00M0.00M0.00M0.00M
Non-Current Assets (Quarter)
0.49M0.44M0.49M0.46M0.41M0.37M0.30M0.26M0.21M0.04M-1.11M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M
Assets (Quarter)
27.94M25.17M22.16M20.14M15.79M12.81M9.71M12.30M9.54M9.36M5.74M5.30M5.87M5.74M13.44M11.30M11.51M21.49M17.41M14.31M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
0.32M0.28M0.33M1.15M0.54M0.78M0.90M0.64M0.17M0.66M0.32M0.34M0.18M0.25M0.43M0.23M0.52M0.43M0.26M0.90M
Payables (Quarter)
0.32M0.28M0.33M1.15M0.54M0.78M0.90M0.64M0.17M0.66M0.32M0.34M0.18M0.25M0.43M0.23M0.52M0.43M0.26M0.90M
Accumulated Expenses (Quarter)
2.06M0.57M2.12M1.76M1.52M1.02M1.36M1.65M2.08M0.94M0.93M1.19M0.73M0.76M0.84M0.97M1.15M0.91M0.69M0.80M
Other Accumulated Expenses (Quarter)
0.02M0.08M0.02M
Current Leases (Quarter)
0.11M0.12M0.13M0.13M0.13M0.14M0.14M0.10M0.07M0.04M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)
2.50M3.07M2.57M3.04M2.19M1.94M2.40M2.39M2.33M1.63M1.25M1.52M0.92M1.01M1.27M1.21M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Preferred Stock Liabilities (Quarter)
0.00M
Operating Leases (Quarter)
0.31M0.29M0.27M0.10M0.20M0.17M0.04M
Non-Current Deferred Tax Liability (Quarter)
0.08M0.04M0.01M
Total Liabilities (Quarter)
2.70M3.24M2.71M3.14M2.26M1.97M2.40M2.39M2.33M1.63M5.74M5.30M5.87M1.01M1.27M1.21M1.67M1.34M0.95M1.71M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)
25.25M21.93M19.45M17.00M13.53M10.84M7.31M9.90M7.21M7.73M5.60M3.77M4.95M4.72M12.17M10.10M9.84M20.15M16.46M12.60M
Liabilities and Shareholders Equity (Quarter)
27.94M25.17M22.16M20.14M15.79M12.81M9.71M12.30M9.54M9.36M5.74M5.30M5.87M5.74M13.44M11.30M11.51M21.49M17.41M14.31M
Retained Earnings (Quarter)
138.69M-116.90M-119.54M-122.07M139.18M139.22M-131.98M144.44M-137.31M146.94M-141.36M-143.21M-144.73M151.08M-148.12M-150.29M-152.68M175.20M-159.06M175.80M
Preferred Shares (Quarter)
Treasury Shares (Quarter)
0.37M0.03M0.89M0.69M0.68M0.01M0.07M0.07M0.07M0.01M0.02M0.00M0.07M0.07M0.07M0.07M0.51M0.48M0.83M0.79M